Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...
Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates ...
GLP-1 agonists work by triggering the pancreas to produce more insulin, which reduces blood sugar levels in those with type 2 ...
While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.
PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...
A growing number of ... the blockbuster weight-loss drugs, several surveys show. Workers will learn whether they’ll gain such coverage for the coming year during open enrollment, which launches ...
When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound ... medications say coverage has a ...
To keep up to date with the latest Number 1s each week, sign up to our newsletter. Unsubscribe at any time.
While additional drugs in the same class are sure to earn FDA approval in the coming years, Eli Lilly is well positioned in ...
Though iron deficiencies aren’t routinely checked for, they can have a big impact on your quality of life. If you’re iron ...